Argus lifted their target price on shares of Eli Lilly and Company from $470.00 to $620.00 and gave the stock a “buy” rating in a research note on Tuesday, September 5th.

Source: https://www.dailypolitical.com/2023/12/16/rise-advisors-llc-boosts-holdings-in-eli-lilly-and-company-nyselly.html

Armstrong Advisory Group Inc.’s holdings in Eli Lilly and Company were worth $3,447,000 as of its most recent SEC filing.

Source: https://www.dailypolitical.com/2023/12/19/armstrong-advisory-group-inc-sells-36-shares-of-eli-lilly-and-company-nyselly.html

Barclays Adjusts Price Target on Eli Lilly and Company to $400 From $395, Maintains Ove.

Source: https://www.marketscreener.com/quote/stock/ELI-LILLY-AND-COMPANY-13401/news/FDA-Approves-Eli-Lilly-s-Jaypirca-to-Treat-Lymphoma-Patients-42832640/?utm_medium=RSS&utm_content=20230127

Bell Investment Advisors Inc’s holdings in Eli Lilly and Company were worth $137,000 at the end of the most recent quarter.

Source: https://www.etfdailynews.com/2023/11/14/bell-investment-advisors-inc-acquires-67-shares-of-eli-lilly-and-company-nyselly/

Bogart Wealth LLC raised its position in Eli Lilly and Company by 193.3% during the first quarter.

Source: https://www.dailypolitical.com/2023/08/11/sco-inc-decreases-position-in-eli-lilly-and-company-nyselly.html

Burney Co.’s holdings in Eli Lilly and Company were worth $18,012,000 at the end of the most recent reporting period.

Source: https://www.etfdailynews.com/2023/11/14/burney-co-reduces-stock-holdings-in-eli-lilly-and-company-nyselly/

Castle Rock Wealth Management LLC purchased a new stake in shares of Eli Lilly and Company () in the fourth quarter, according to the company in its most recent 13F filing with the SEC.

Source: https://www.americanbankingnews.com/2023/04/12/castle-rock-wealth-management-llc-purchases-shares-of-745-eli-lilly-and-company-nyselly.html

Eli Lilly and Company) is a pharmaceutical company best known for producing Prozac, Cymbalta, and Zyprexa.

Source: https://investorplace.com/2023/08/the-3-blue-chip-stocks-every-investor-needs-to-own-today/

Eli Lilly and Company () last announced its earnings results on Thursday, November 2nd.

Source: https://www.etfdailynews.com/2023/12/03/eli-lilly-and-company-nyselly-rating-reiterated-by-truist-financial/

Eli Lilly and Company () last posted its quarterly earnings results on Thursday, April 27th.

Source: https://www.americanbankingnews.com/2023/07/03/eli-lilly-and-company-nyselly-shares-sold-by-oak-harvest-investment-services.html

Fairfield Bush & CO. purchased a new stake in shares of Eli Lilly and Company in the 1st quarter valued at $107,000.

Source: https://www.etfdailynews.com/2023/10/07/eli-lilly-and-company-nyselly-shares-acquired-by-carret-asset-management-llc-2/

Finally, Barometer Capital Management Inc. bought a new stake in shares of Eli Lilly and Company in the 1st quarter valued at approximately $561,000.

Source: https://www.etfdailynews.com/2023/11/12/barden-capital-management-inc-raises-stock-holdings-in-eli-lilly-and-company-nyselly/

Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $630.00 price objective on shares of Eli Lilly and Company in a report on Wednesday, November 15th.

Source: https://www.dailypolitical.com/2023/12/17/eli-lilly-and-company-nyselly-shares-sold-by-lvm-capital-management-ltd-mi.html

Finally, Citigroup upped their target price on Eli Lilly and Company from $360.00 to $525.00 and gave the stock a “buy” rating in a research report on Wednesday, July 26th.

Source: https://www.etfdailynews.com/2023/09/17/evanson-asset-management-llc-has-568000-stock-position-in-eli-lilly-and-company-nyselly/

Finally, Credit Suisse Group raised their price objective on Eli Lilly and Company from $490.00 to $580.00 and gave the company an “outperform” rating in a report on Wednesday, August 9th.

Source: https://www.etfdailynews.com/2023/09/24/eli-lilly-and-company-nyselly-shares-acquired-by-relyea-zuckerberg-hanson-llc/

Finally, Envestnet Asset Management Inc. boosted its position in Eli Lilly and Company by 316.9% in the first quarter.

Source: https://www.dailypolitical.com/2023/12/19/armstrong-advisory-group-inc-sells-36-shares-of-eli-lilly-and-company-nyselly.html

Finally, Mizuho Markets Americas LLC increased its stake in shares of Eli Lilly and Company by 2,882.6% during the 1st quarter.

Source: https://www.etfdailynews.com/2023/09/17/bard-financial-services-inc-has-2-70-million-stock-holdings-in-eli-lilly-and-company-nyselly/

Finally, RVW Wealth LLC acquired a new stake in shares of Eli Lilly and Company during the 3rd quarter valued at $46,000.

Source: https://www.dailypolitical.com/2023/12/22/eli-lilly-and-company-nyselly-shares-bought-by-congress-park-capital-llc.html

Finally, Tanglewood Legacy Advisors LLC purchased a new stake in Eli Lilly and Company during the fourth quarter valued at approximately $37,000.

Source: https://www.americanbankingnews.com/2023/07/11/eli-lilly-and-company-nyselly-holdings-lifted-by-mn-services-vermogensbeheer-b-v.html

Finally, Truist Financial reissued a “buy” rating and set a $650.00 target price on shares of Eli Lilly and Company in a research note on Wednesday, November 29th.

Source: https://www.dailypolitical.com/2023/12/19/armstrong-advisory-group-inc-sells-36-shares-of-eli-lilly-and-company-nyselly.html